行動基因生技股份有限公司
ACT Genomics is a leading precision oncology company headquartered in Taiwan with extended footprints in China, Japan, Hong Kong and Singapore. With our certified NGS platform and comprehensive genomic profiling, we help patients find the right treatments. At the same time, we collaborate with bio-pharmaceutical companies to accelerate clinical trials in drug development and CDX development. Our expertise in bioinformatics and medical interpretation enables us to deliver comprehensive and comprehensible medical reports and build cancer genomics database.